A protein known as butyryl protein (BTN), which shares an epitope with the myelin oligodendrocyte glycoprotein (MOG), was identified in milk, and transdermal administration of msEVs to patients with multiple sclerosis induced the development of MOG-specific tolerance for use in MOG-specific immunotherapy [137]. This evidence concerns the gene MOG and multiple sclerosis.